Featured Research

from universities, journals, and other organizations

New Tool Developed To Gauge Quality Of Life Of Hepatitis B Patients

Date:
July 12, 2007
Source:
University of California - Los Angeles
Summary:
In a new study researchers measured the effect of hepatitis B on patients' quality of life -- beyond just the physical symptoms of the disease -- and created a new tool to better assess patients' overall well-being, which may help clinicians guide treatment.

"Am I going to die? I have no future." "I feel depressed at times, fearful I may not see my children marry or be a grandparent." Such heart-rending statements from patients with chronic hepatitis B reveal the social and mental impact of this disease, which affects 350 million worldwide.

Related Articles


In a new study, UCLA researchers measured the effect of hepatitis B on patients' quality of life -- beyond just the physical symptoms of the disease -- and created a new tool to better assess patients' overall well-being, which may help clinicians guide treatment. The study appears in the July issue of the journal Hepatology.

"Our results revealed that to effectively treat hepatitis B patients, clinicians need to consider the social and psychological impact of the disease, as well as biological functioning," said Dr. Brennan M.R. Spiegel, principal investigator and assistant professor of medicine at the David Geffen School of Medicine at UCLA and the Veterans Affairs Greater Los Angeles Healthcare System.

Hepatitis B is caused by a viral infection that can damage the liver and lead to chronic disease. It is contracted most often through contact with infected blood or bodily fluids.

According to Spiegel, little research had been done previously on quality-of-life issues for the majority of hepatitis B patients -- those who do not have advanced liver disease or, even rarer, end-stage complications.

In developing the first-of-its-kind assessment tool for patients, researchers reviewed existing literature, conducted a focus group with health experts and interviewed hepatitis patients. They then took the information and developed a patient questionnaire that clinicians could use to measure patients' quality of life.

"We were shocked to find that for many hepatitis B patients without advanced liver disease, the psychosocial impact of the disease affected their lives more than the physical symptoms," said Spiegel, who is also director of the UCLA/VA Center for Outcomes Research and Education. "No one had ever documented this before."

The questionnaire measures quality of life on several levels, including psychological well-being, anxiety, vitality, disease stigma, vulnerability and transmissibility.

"We hope that this quick questionnaire can become a 'vital sign' taken in the doctor's office to help see how the patient is doing," added Spiegel.

Spiegel notes that the questionnaire could also be used in clinical trials to help measure outcomes and also to equip patients with knowledge to help them better select between competing disease management strategies.

The study was funded by the pharmaceutical company Novartis. Spiegel is a consultant for Novartis and has received research support form the company.

Other study authors from the David Geffen School of Medicine at UCLA include Roger Bolus, Ph.D., Dr. Eric Esrailian and Jennifer Talley, also of the UCLA/VA Center for Outcomes Research and Education; Dr. Steven Han, also of the VA Greater Los Angeles Healthcare System; Dr. Myron Tong; and Dr. Francisco Durazo.

Other authors include Dr. Tram Tran, Cedars-Sinai Medical Center; Jason Smith, Pharm.D., VA Greater Los Angeles Healthcare System; Dr. Hetal A. Karsan, Atlanta Gastroenterology Associates and Emory University School of Medicine; Dr. Bruce Bacon, Center for Liver Diseases at Inova Faifax Hospital in Virginia; Dr. Paul Martin, Emory University School of Medicine; Dr. Zobair Younossi, Center for Liver Diseases at Inova Fairfax Hospital; Siew Hwa-Ong, Novartis Pharma AG in Basel, Switzerland; and Dr. Fasiha Kanwal, St. Louis University.


Story Source:

The above story is based on materials provided by University of California - Los Angeles. Note: Materials may be edited for content and length.


Cite This Page:

University of California - Los Angeles. "New Tool Developed To Gauge Quality Of Life Of Hepatitis B Patients." ScienceDaily. ScienceDaily, 12 July 2007. <www.sciencedaily.com/releases/2007/07/070711001353.htm>.
University of California - Los Angeles. (2007, July 12). New Tool Developed To Gauge Quality Of Life Of Hepatitis B Patients. ScienceDaily. Retrieved November 29, 2014 from www.sciencedaily.com/releases/2007/07/070711001353.htm
University of California - Los Angeles. "New Tool Developed To Gauge Quality Of Life Of Hepatitis B Patients." ScienceDaily. www.sciencedaily.com/releases/2007/07/070711001353.htm (accessed November 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, November 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins